Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials
These medications also aid in weight loss by reducing appetite, slowing stomach emptying, and promoting a feeling of fullness
Abbreviations GCLC: Glutamate cysteine ligase catalytic subunit GCLM: Glutamate cysteine ligase modifier subunit GSH: Reduced glutathione GSSG: Oxidized glutathione ROS: Reactive oxygen species C1q: Complement component 1q C3: Complement component 3 GSDMD: Gasdermin D GSDME: Gasdermin E DAM: Disease associated microglia DAA: Disease associated astrocyte Iba1: Ionized calcium-binding adapter molecule 1 GFAP: Glial fibrillary acidic protein NeuN: Neuronal nuclei HO1: Hemeoxygenase 1 CCL: CC Chemokine ligand CXCL: C-X-C motif ligand AD: Alzheimers disease App: Amyloid precursor protein A: Amyloid beta App : NL-G-F App knockin mouse NL-G-F References Guo, C., Sun, L., Chen, X
Type 2 diabetes is not inherently insulin-dependent
Each effervescent tablet contains powerful glutathione to target dullness, dark spots, and pigmentation